India's Disease Outbreak Response: A Bold Regional Overhaul
New Delhi's Ambitious Plan: India is gearing up for a transformative change in its approach to infectious disease outbreaks, and the upcoming Union budget might be a game-changer. The government is considering a significant restructuring of the National Centre for Disease Control (NCDC), aiming to decentralize and enhance the country's outbreak response capabilities, according to two well-informed officials.
Expanding the NCDC's Reach: The proposed plan involves a comprehensive expansion of the NCDC's infrastructure. This includes the establishment of five regional offices, 20 metropolitan surveillance units, and 27 state regional centres, all under India's leading public health institute. But here's where it gets controversial: some experts question if this expansion is enough to cover the vast and diverse Indian population.
Strengthening Disease Surveillance: The Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) is set to introduce a new strategy. The plan involves creating 10 biosafety level-3 (BSL-3) laboratories to enhance field-level diagnostics, a crucial step in pandemic preparedness. These labs are essential for containing airborne pathogens and detecting emerging diseases.
Specialized Units for Urban Health: The proposal also includes specialized units to address health security in crowded cities, focusing on sanitation and overcrowding. This shift in responsibility gives NCDC the lead in frontline service delivery, evidence collection, and field surveillance, while the Indian Council of Medical Research (ICMR) focuses on medical research.
High-Containment Laboratories: India currently operates 35 BSL-3 laboratories, with only one biosafety level 4 (BSL-4) laboratory at the National Institute of Virology Pune, handling the most dangerous pathogens. This limited capacity has been a concern, especially with the rise of zoonotic diseases like nipah, zika, and avian influenza, which have caused numerous fatalities in recent years.
Budgetary Support: The PM-ABHIM scheme, with its ₹64,180 crore budget, is set to end in the current fiscal year. From FY27, fresh funds will be allocated to support disease surveillance and laboratory maintenance. The exact amount remains undisclosed, as the government finalizes allocations closer to the budget announcement, considering various economic factors.
NCDC's Current Role: Headquartered in New Delhi, NCDC manages the Indian SARS-CoV-2 genomics consortium (INSACOG) for COVID-19 variant surveillance. It has eight branches across India, but the question remains: is this sufficient to cater to the country's vast and diverse population?
A Strategic Upgrade: According to a government official, the upgrade aims to strengthen the public health network, enabling quicker infection identification and containment. This move is seen as a step towards a pandemic-resilient healthcare system, addressing the critical gaps exposed by recent outbreaks.
Addressing Laboratory Shortages: India's bio-safety lab count stood at 237 in March 2025, but experts argue that this is far from enough. With increasing zoonotic threats, the country needs a more extensive network to ensure timely high-containment testing without samples traveling long distances.
A Network of Laboratories: Various organizations contribute to India's laboratory network. The Department of Health Research (DHR) operates 165 labs, including BSL-3 and BSL-2 facilities. ICMR, DBT, CSIR, ICAR, and ANRF also run specialized labs, with ICMR managing the country's sole BSL-4 facility. This network is vital, but is it truly equipped to handle the nation's diverse health challenges?
Expert Insights: Dr. Sujeet Singh, a former NCDC director, emphasizes the need to move beyond post-pandemic complacency. He highlights the limited laboratory capacity during recent outbreaks, advocating for at least 15 BSL-3 labs and a dedicated BSL-4 facility for human samples. Raman Gangakhedkar, a former ICMR scientist, agrees, stating that the revamp is crucial for future survival, but also notes ICMR's primary focus on research and evidence generation.
Urban Health Challenges: With India's population surpassing China's in 2023, its mega-cities face immense health security concerns. Dr. Singh stresses the importance of specialized metropolitan surveillance units to manage urban health, especially in crowded cities, where unique challenges like sanitation and overcrowding require tailored solutions.
The Road Ahead: As India prepares for this overhaul, the question remains: will this expansion truly revolutionize the country's disease outbreak response, or are there underlying challenges that need further attention? The upcoming budget and the government's commitment to public health will be pivotal in shaping India's future resilience to infectious diseases. What do you think? Is India on the right track, or are there aspects of this plan that require reevaluation?
